Income Statement Peptron, Inc.

Equities

A087010

KR7087010005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2025-06-23			5-day change	1st Jan Change
190,700.00 ^KRW	-4.41%		+2.42%	+87.33%

2024	Peptron Signs Deal with Eli Lilly for Peptide Drug Research	MT
2023	Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal	MT

51ffc88.Bu7oPRXNfXNTkBcc3PkunIlK3i02_zDqP640x7MvdY4.b6esVUWiSEZhxHJDtYlq1cEepl14smKhb-xn89xLH-xLpN9kc6YRJiLbTg

Published financial data: PEPTRON, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3.12B	6.62B	5.81B	3.34B	3.15B
Other Revenues, Total	10	10	-	-	-
Total Revenues	3.12B	6.62B	5.81B	3.34B	3.15B
Cost of Goods Sold, Total	2.11B	2.16B	2.54B	2.29B	2.21B
Gross Profit	1.01B	4.47B	3.27B	1.05B	937M
Selling General & Admin Expenses, Total	4.19B	5B	4.86B	5.21B	4.92B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	14.18B	14.84B	13.37B	11.44B	12.14B
Depreciation & Amortization - (IS)	151M	177M	168M	163M	282M
Amortization of Goodwill and Intangible Assets - (IS)	93.13M	102M	101M	118M	124M
Other Operating Expenses, Total	18.62B	20.12B	18.5B	16.94B	17.47B
Operating Income	-17.61B	-15.66B	-15.23B	-15.88B	-16.53B
Interest Expense, Total	-	-36.84M	-280M	-396M	-473M
Interest And Investment Income	141M	475M	423M	242M	672M
Net Interest Expenses	141M	439M	143M	-154M	199M
Currency Exchange Gains (Loss)	7.95M	192M	192M	96.06M	229M
Other Non Operating Income (Expenses)	-705M	-244M	-685K	1.75M	109M
EBT, Excl. Unusual Items	-18.16B	-15.27B	-14.89B	-15.94B	-15.99B
Gain (Loss) On Sale Of Investments	-	5.28M	7.1M	2.83M	-2.47B
Gain (Loss) On Sale Of Assets	-1K	-913K	-162M	3.47M	-3.15B
Asset Writedown	-173M	-15.96M	-19.49M	-7.05M	-8.71M
EBT, Incl. Unusual Items	-18.34B	-15.28B	-15.07B	-15.94B	-21.62B
Income Tax Expense	46.81M	-242M	-4.21M	-18.94M	414M
Earnings From Continuing Operations	-18.38B	-15.04B	-15.06B	-15.92B	-22.03B
Net Income to Company	-18.38B	-15.04B	-15.06B	-15.92B	-22.03B
Net Income - (IS)	-18.38B	-15.04B	-15.06B	-15.92B	-22.03B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-18.38B	-15.04B	-15.06B	-15.92B	-22.03B
Net Income to Common Excl. Extra Items	-18.38B	-15.04B	-15.06B	-15.92B	-22.03B
Per Share Items
Net EPS - Basic	-1.2K	-729.24	-730.25	-773.61	-1.06K
Basic EPS - Continuing Operations	-1.2K	-729.24	-730.25	-773.61	-1.06K
Basic Weighted Average Shares Outstanding	15.37M	20.63M	20.63M	20.58M	20.77M
Net EPS - Diluted	-1.2K	-729.24	-730.25	-773.61	-1.06K
Diluted EPS - Continuing Operations	-1.2K	-729.24	-730.25	-773.61	-1.06K
Diluted Weighted Average Shares Outstanding	15.37M	20.63M	20.63M	20.58M	20.77M
Normalized Basic EPS	-738.53	-462.75	-451.24	-484.06	-481.11
Normalized Diluted EPS	-738.53	-462.75	-451.24	-484.06	-481.11
Supplemental Items
EBITDA	-14.34B	-12.15B	-10.17B	-12.99B	-13.84B
EBITA	-17.45B	-15.56B	-15.13B	-15.77B	-16.4B
EBIT	-17.61B	-15.66B	-15.23B	-15.88B	-16.53B
EBITDAR	-14.34B	-	-	-	-
Effective Tax Rate - (Ratio)	-0.26	1.58	0.03	0.12	-1.92
Normalized Net Income	-11.35B	-9.55B	-9.31B	-9.96B	-9.99B
Supplemental Operating Expense Items
Advertising Expense	7.09M	8.59M	15.58M	8.29M	7.41M
Selling and Marketing Expenses	1.35B	1.63B	1.42B	1.34B	1.16B
Research And Development Expense From Footnotes	14.18B	14.84B	13.37B	11.44B	12.14B
Net Rental Expense, Total	2.69M	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Maintenance & Repair Expenses, Total	127M	76.79M	49.15M	86.91M	170M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	67.97B	4.64B	5.04B	4.26B	1.05B
Short Term Investments	2.63B	23.5B	9.6B	718M	109B
Trading Asset Securities, Total	-	2.1B	2.6B	-	13.95B
Total Cash And Short Term Investments	70.6B	30.24B	17.24B	4.98B	124B
Accounts Receivable, Total	412M	387M	371M	415M	331M
Other Receivables	8.5M	249M	163M	29.85M	334M
Notes Receivable	-	-	2.58B	999M	-
Total Receivables	421M	636M	3.11B	1.44B	665M
Inventory	105M	705M	814M	172M	258M
Prepaid Expenses	330M	33.24M	185M	49.6M	244M
Other Current Assets, Total	660M	1.06B	1.93B	1.32B	1.41B
Total Current Assets	72.12B	32.67B	23.28B	7.97B	126B
Gross Property Plant And Equipment	53B	53.71B	61.04B	61.73B	52.38B
Accumulated Depreciation	-12.24B	-15.64B	-20.29B	-23.04B	-25.45B
Net Property Plant And Equipment	40.76B	38.07B	40.74B	38.68B	26.93B
Long-term Investments	82.09M	2.61B	2.62B	2.6B	11.54B
Other Intangibles, Total	647M	605M	675M	687M	958M
Accounts Receivable Long-Term	-	-	340	-	180
Loans Receivable Long-Term	3.38B	2.68B	-	-	-
Deferred Charges Long-Term	0	-	-	1.13B	1.88B
Other Long-Term Assets, Total	722M	1.23B	958M	1.43B	1.11B
Total Assets	118B	77.87B	68.27B	52.5B	169B
Liabilities
Accounts Payable, Total	725M	572M	642M	223M	478M
Accrued Expenses, Total	235M	220M	241M	307M	343M
Short-term Borrowings	26.71B	-	3B	4.55B	990M
Current Portion of Long-Term Debt	-	3B	6.05B	-	-
Current Portion of Leases	97.04M	54.65M	94.95M	57.89M	102M
Current Income Taxes Payable	-	-	-	-	56.04M
Other Current Liabilities	819M	2.76B	745M	1.75B	3.13B
Total Current Liabilities	28.59B	6.6B	10.77B	6.88B	5.1B
Long-Term Debt	9.05B	6.05B	-	4.5B	8.06B
Long-Term Leases	91.17M	52.26M	81.89M	26.1M	85.28M
Pension & Other Post Retirement Benefits	2.16B	2.32B	2.15B	2.67B	2.86B
Deferred Tax Liability Non Current	317M	92.54M	1.63B	1.55B	337M
Other Non Current Liabilities	368M	465M	534M	732M	743M
Total Liabilities	40.57B	15.59B	15.17B	16.37B	17.18B
Preferred Stock Non Redeemable	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	10.31B	10.31B	10.31B	10.31B	11.65B
Additional Paid In Capital	133B	133B	15.47B	15.75B	152B
Retained Earnings	-67.07B	-82.05B	20.21B	4.89B	-13.54B
Treasury Stock	-	-	-	-891M	-891M
Comprehensive Income and Other	1.36B	1.48B	7.12B	6.06B	2.78B
Total Common Equity	77.13B	62.28B	53.11B	36.13B	152B
Total Equity	77.13B	62.28B	53.11B	36.13B	152B
Total Liabilities And Equity	118B	77.87B	68.27B	52.5B	169B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.63M	20.63M	20.63M	20.55M	23.22M
ECS Total Common Shares Outstanding	20.63M	20.63M	20.63M	20.55M	23.22M
Book Value / Share	3.74K	3.02K	2.57K	1.76K	6.53K
Tangible Book Value	76.49B	61.68B	52.43B	35.44B	151B
Tangible Book Value Per Share	3.71K	2.99K	2.54K	1.72K	6.49K
Total Debt	35.95B	9.16B	9.23B	9.13B	9.24B
Net Debt	-34.65B	-21.08B	-8.02B	4.15B	-115B
Debt Equivalent Oper. Leases	21.51M	-	-	-	-
Inventories - Raw Materials, Total	36.76M	29.46M	52.16M	53.55M	42.4M
Inventories - Work In Process, Total	-	374M	425M	-	-
Inventories - Finished Goods, Total	84.96M	318M	354M	136M	232M
Inventories - Others	-660	-680	-800	-640	-200
Land - (BS)	8.99B	15.47B	22.57B	22.7B	12.19B
Buildings, Total	12.01B	12.01B	12.13B	12.13B	12.13B
Machinery, Total	10.83B	10.87B	11.42B	11.51B	12.16B
Accumulated Allowance for Doubtful Accounts (Supple)	526K	526K	526K	526K	2.33M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-18.38B	-15.04B	-15.06B	-15.92B	-22.03B
Depreciation & Amortization - CF	3.11B	3.41B	4.95B	2.78B	2.57B
Amortization of Goodwill and Intangible Assets - (CF)	154M	102M	101M	118M	124M
Depreciation & Amortization, Total	3.27B	3.51B	5.05B	2.89B	2.69B
(Gain) Loss From Sale Of Asset	1K	913K	162M	-3.47M	3.15B
(Gain) Loss on Sale of Investments - (CF)	-	-5.28M	-7.1M	-2.83M	2.47B
Asset Writedown & Restructuring Costs	173M	15.96M	19.49M	7.05M	8.71M
Stock-Based Compensation (CF)	48.5M	128M	97.61M	8.31M	-
Provision and Write-off of Bad Debts	-	-	-	-	1.8M
Other Operating Activities, Total	1.47B	-130M	669M	869M	614M
Change In Accounts Receivable	-341M	24.54M	16.86M	-44.26M	81.72M
Change In Inventories	-80.57M	-600M	-109M	641M	-85.32M
Change In Accounts Payable	203M	-154M	70.7M	-418M	255M
Change in Other Net Operating Assets	93.83M	1.64B	-2.63B	997M	80.47M
Cash from Operations	-13.55B	-10.61B	-11.72B	-10.97B	-12.77B
Capital Expenditure	-3.1B	-699M	-1.52B	-731M	-1.01B
Sale of Property, Plant, and Equipment	-	-	836M	19.86M	7.38B
Sale (Purchase) of Intangible assets	-73.02M	-76.17M	-191M	-1.26B	-1.16B
Investment in Marketable and Equity Securities, Total	12.44B	-25.49B	13.4B	11.5B	-134B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-3.38B	701M	95.41M	1.58B	999M
Other Investing Activities, Total	-412M	-310M	-542M	-70M	-55.25M
Cash from Investing	5.48B	-25.88B	12.07B	11.04B	-127B
Long-Term Debt Issued, Total	6.05B	-	-	-	10.05B
Total Debt Issued	6.05B	-	-	-	10.05B
Long-Term Debt Repaid, Total	-68.77M	-26.98B	-102M	-101M	-10.16B
Total Debt Repaid	-68.77M	-26.98B	-102M	-101M	-10.16B
Issuance of Common Stock	68.9B	-	-	-	139B
Repurchase of Common Stock	-	-	-	-891M	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-1.28B	80.51M	54.38M	139M	-2.18B
Cash from Financing	73.61B	-26.9B	-47.81M	-853M	137B
Foreign Exchange Rate Adjustments	-12M	64.87M	95.9M	12.06M	128M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	65.52B	-63.33B	402M	-775M	-3.22B
Supplemental Items
Cash Interest Paid	219M	254M	273M	379M	484M
Cash Income Tax Paid (Refund)	-83.09M	320M	41.99M	-19.73M	-14.38M
Levered Free Cash Flow	-10.47B	-6.23B	-11.88B	-5.57B	-7.97B
Unlevered Free Cash Flow	-10.47B	-6.2B	-11.7B	-5.32B	-7.68B
Change In Net Working Capital	-439M	-849M	5.52B	-3.71B	-2.13B
Net Debt Issued / Repaid	5.98B	-26.98B	-102M	-101M	-107M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-12.32	-10.01	-13.02	-16.44	-9.33
Return on Total Capital	-12.92	-10.61	-14.23	-18.45	-10.02
Return On Equity %	-34.94	-21.58	-26.11	-35.68	-23.46
Return on Common Equity	-34.94	-21.58	-26.11	-35.68	-23.46
Margin Analysis
Gross Profit Margin %	32.36	67.42	56.26	31.53	29.74
SG&A Margin	134.31	75.54	83.6	155.99	156.21
EBITDA Margin %	-459.5	-183.39	-174.96	-388.69	-438.96
EBITA Margin %	-559.22	-234.83	-260.16	-471.76	-520.39
EBIT Margin %	-564.17	-236.37	-261.9	-475.3	-524.33
Income From Continuing Operations Margin %	-589.03	-227.07	-259.08	-476.43	-699
Net Income Margin %	-589.03	-227.07	-259.08	-476.43	-699
Net Avail. For Common Margin %	-589.03	-227.07	-259.08	-476.43	-699
Normalized Net Income Margin	-363.74	-144.09	-160.09	-298.11	-317.06
Levered Free Cash Flow Margin	-335.48	-93.98	-204.29	-166.62	-252.86
Unlevered Free Cash Flow Margin	-335.48	-93.64	-201.28	-159.22	-243.49
Asset Turnover
Asset Turnover	0.03	0.07	0.08	0.06	0.03
Fixed Assets Turnover	0.08	0.17	0.15	0.08	0.1
Receivables Turnover (Average Receivables)	12.93	16.57	15.33	8.51	8.45
Inventory Turnover (Average Inventory)	32.81	5.33	3.35	4.64	10.31
Short Term Liquidity
Current Ratio	2.52	4.95	2.16	1.16	24.81
Quick Ratio	2.48	4.68	1.65	0.79	24.44
Operating Cash Flow to Current Liabilities	-0.47	-1.61	-1.09	-1.59	-2.5
Days Sales Outstanding (Average Receivables)	28.31	22.03	23.8	42.9	43.31
Days Outstanding Inventory (Average Inventory)	11.16	68.46	108.96	78.62	35.5
Average Days Payable Outstanding	104.18	85.81	83.49	95.85	55.81
Cash Conversion Cycle (Average Days)	-64.72	4.68	49.27	25.67	23.01
Long Term Solvency
Total Debt/Equity	46.6	14.7	17.37	25.28	6.09
Total Debt / Total Capital	31.79	12.82	14.8	20.18	5.74
LT Debt/Equity	11.85	9.8	0.15	12.53	5.37
Long-Term Debt / Total Capital	8.08	8.54	0.13	10	5.06
Total Liabilities / Total Assets	34.47	20.02	22.21	31.18	10.17
EBIT / Interest Expense	-	-425.04	-54.45	-40.11	-34.95
EBITDA / Interest Expense	-	-329.77	-36.37	-32.8	-29.26
(EBITDA - Capex) / Interest Expense	-	-348.74	-41.83	-34.64	-31.39
Total Debt / EBITDA	-2.51	-0.75	-0.91	-0.7	-0.67
Net Debt / EBITDA	2.42	1.74	0.79	-0.32	8.29
Total Debt / (EBITDA - Capex)	-2.06	-0.71	-0.79	-0.67	-0.62
Net Debt / (EBITDA - Capex)	1.99	1.64	0.69	-0.3	7.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	73.26	112.28	-12.24	-42.52	-5.68
Gross Profit, 1 Yr. Growth %	78.07	342.32	-26.77	-67.78	-11.03
EBITDA, 1 Yr. Growth %	42.65	-15.28	-16.27	27.7	6.52
EBITA, 1 Yr. Growth %	39.04	-10.86	-2.77	4.23	4.05
EBIT, 1 Yr. Growth %	38.59	-11.06	-2.76	4.32	4.05
Earnings From Cont. Operations, 1 Yr. Growth %	3.75	-18.17	0.14	5.7	38.39
Net Income, 1 Yr. Growth %	3.75	-18.17	0.14	5.7	38.39
Normalized Net Income, 1 Yr. Growth %	3.03	-15.91	-2.49	7.04	0.32
Diluted EPS Before Extra, 1 Yr. Growth %	3.46	-39.03	0.17	5.97	37.04
Accounts Receivable, 1 Yr. Growth %	483.09	-5.96	-4.3	11.85	-20.13
Inventory, 1 Yr. Growth %	334.96	573.77	15.4	-78.83	49.55
Net Property, Plant and Equip., 1 Yr. Growth %	1.13	-6.59	7.02	-5.05	-30.4
Total Assets, 1 Yr. Growth %	93	-33.84	-12.32	-23.11	221.73
Tangible Book Value, 1 Yr. Growth %	178.96	-19.36	-14.99	-32.41	325.37
Common Equity, 1 Yr. Growth %	174.63	-19.25	-14.73	-31.98	319.93
Cash From Operations, 1 Yr. Growth %	41.16	-21.66	10.41	-6.37	16.34
Capital Expenditures, 1 Yr. Growth %	-38.12	-77.45	118.27	-52.05	37.92
Levered Free Cash Flow, 1 Yr. Growth %	-2.98	-40.53	90.77	-53.12	43.14
Unlevered Free Cash Flow, 1 Yr. Growth %	-2.98	-40.75	88.66	-54.53	44.24
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-10.11	91.78	36.49	-28.97	-26.37
Gross Profit, 2 Yr. CAGR %	-14.81	180.65	79.97	-51.43	-46.46
EBITDA, 2 Yr. CAGR %	43.06	9.93	-15.78	3.4	16.63
EBITA, 2 Yr. CAGR %	50	11.33	-6.9	0.67	4.14
EBIT, 2 Yr. CAGR %	49.23	11.02	-7	0.72	4.19
Earnings From Cont. Operations, 2 Yr. CAGR %	122.12	-7.86	-9.48	2.88	20.95
Net Income, 2 Yr. CAGR %	122.12	-7.86	-9.48	2.88	20.95
Normalized Net Income, 2 Yr. CAGR %	121.44	-6.92	-9.45	2.16	3.62
Diluted EPS Before Extra, 2 Yr. CAGR %	121.85	-20.58	-21.86	3.01	20.54
Accounts Receivable, 2 Yr. CAGR %	220.76	134.17	-5.13	3.46	-5.48
Inventory, 2 Yr. CAGR %	104.21	441.35	178.84	-50.58	-43.74
Net Property, Plant and Equip., 2 Yr. CAGR %	3.68	-2.81	-0.02	0.8	-18.71
Total Assets, 2 Yr. CAGR %	28.07	13	-23.84	-17.89	57.28
Tangible Book Value, 2 Yr. CAGR %	31.19	49.98	-17.2	-24.2	69.56
Common Equity, 2 Yr. CAGR %	30.78	48.92	-17.02	-23.84	69.01
Cash From Operations, 2 Yr. CAGR %	80.04	5.16	-7	1.68	4.37
Capital Expenditures, 2 Yr. CAGR %	-44.71	-62.65	-29.84	2.3	-18.68
Levered Free Cash Flow, 2 Yr. CAGR %	-7.46	-24.04	6.51	-5.43	-18.08
Unlevered Free Cash Flow, 2 Yr. CAGR %	-7.46	-24.18	5.73	-7.38	-19.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.99	19.71	47.79	2.31	-21.93
Gross Profit, 3 Yr. CAGR %	-4.62	47.52	79.34	1.43	-40.57
EBITDA, 3 Yr. CAGR %	50.82	20.14	0.4	-3.24	4.43
EBITA, 3 Yr. CAGR %	56.19	26.11	6.41	-3.33	1.78
EBIT, 3 Yr. CAGR %	54.5	25.58	6.22	-3.37	1.82
Earnings From Cont. Operations, 3 Yr. CAGR %	60.73	59.23	-5.27	-4.68	13.57
Net Income, 3 Yr. CAGR %	60.73	59.23	-5.27	-4.68	13.57
Normalized Net Income, 3 Yr. CAGR %	61.62	60.36	-5.47	-4.26	1.54
Diluted EPS Before Extra, 3 Yr. CAGR %	25.14	44.24	-14.2	-13.52	13.31
Accounts Receivable, 3 Yr. CAGR %	-16.98	113.09	73.78	0.22	-5.09
Inventory, 3 Yr. CAGR %	-40.06	204.01	223.39	18.06	-28.52
Net Property, Plant and Equip., 3 Yr. CAGR %	12.62	0.13	0.36	-1.73	-10.9
Total Assets, 3 Yr. CAGR %	30.43	2.76	3.83	-23.6	29.44
Tangible Book Value, 3 Yr. CAGR %	16.67	11.55	24.12	-22.62	34.7
Common Equity, 3 Yr. CAGR %	16.44	11.36	23.66	-22.34	34.55
Cash From Operations, 3 Yr. CAGR %	34.05	36.43	6.88	-6.79	6.35
Capital Expenditures, 3 Yr. CAGR %	-47.85	-59	-32.72	-38.2	13.01
Levered Free Cash Flow, 3 Yr. CAGR %	-26.31	-20.14	3.25	-18.98	8.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	-26.31	-20.24	2.74	-20.2	7.36
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.1	16.17	12.58	-2.85	11.84
Gross Profit, 5 Yr. CAGR %	2.94	30.08	22.96	-5.41	10.58
EBITDA, 5 Yr. CAGR %	44.81	32.61	19.47	13.14	6.6
EBITA, 5 Yr. CAGR %	46.28	36.34	26.99	15.24	5.5
EBIT, 5 Yr. CAGR %	43.93	34.45	26.11	14.98	5.4
Earnings From Cont. Operations, 5 Yr. CAGR %	46.43	36.36	27.75	33.71	4.46
Net Income, 5 Yr. CAGR %	46.43	36.36	27.75	33.71	4.46
Normalized Net Income, 5 Yr. CAGR %	44.78	36.29	28.19	33.9	-1.93
Diluted EPS Before Extra, 5 Yr. CAGR %	18.82	5.24	3.66	26.06	-1.71
Accounts Receivable, 5 Yr. CAGR %	3.95	21.65	-12.43	59.6	36.21
Inventory, 5 Yr. CAGR %	22.83	24.33	10.86	47	60.66
Net Property, Plant and Equip., 5 Yr. CAGR %	54.06	39.96	7.38	0.4	-7.75
Total Assets, 5 Yr. CAGR %	40.29	6.1	5.18	-6.06	22.6
Tangible Book Value, 5 Yr. CAGR %	36	3.49	1.72	-4.43	40.62
Common Equity, 5 Yr. CAGR %	35.46	3.42	1.68	-4.34	40.12
Cash From Operations, 5 Yr. CAGR %	41.89	31.21	15.81	21.29	5.87
Capital Expenditures, 5 Yr. CAGR %	65.52	-24.16	-41.28	-40.9	-27.42
Levered Free Cash Flow, 5 Yr. CAGR %	42.51	5.67	-14.61	-14.55	-5.88
Unlevered Free Cash Flow, 5 Yr. CAGR %	43.45	5.78	-14.86	-15.33	-6.59